Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Dr. Jidong Jia: Advances in Diagnosis and Treatment of Non-Cirrhotic Portal Hypertension

    “Hepatology Digest”: In recent years, what are the major advances in the research of portal hypertension in China? Dr. Jidong Jia: Portal hypertension refers to a group of clinical syndromes caused by an…

    2024.02.26
  • Interview with Recipient of the “Huaxia Youth Medical Science and Technology Award”

    This interview features Dr. Xiaolong Qi, a recipient of the Huaxia Youth Medical Science and Technology Award, one of the most prestigious awards in the Chinese medical field. The Huaxia…

    2024.02.26
  • “The Natural Course of Portal Vein Thrombosis in Cirrhosis.”

    Article Summary Portal vein thrombosis (PVT) refers to the formation of a blood clot in the main trunk of the portal vein and/or its left and right branches, sometimes accompanied…

    2024.02.26
  • Chinese scientist awarded for groundbreaking work in transplantation, cellular therapy

    SAN ANTONIO, the United States, Feb. 24 (Xinhua) — Chinese scientist Huang Xiaojun won a top international award here on Friday for his groundbreaking work known as Beijing Protocol in…

    2024.02.25
  • Tracking international progress and promoting clinical practice updates, Oncology Frontier received awards from the CCHIO conference

    2024.02.24
  • The Future of Hematology: Expert Insights from EHA Conference

    Discover the latest advancements in hematology with our video series covering the European Hematology Association conference. This series offers a comprehensive analysis of pivotal studies such as the A031501/AMBASSADOR trial,…

    2024.02.23
  • ESMO China Voice | Professor Bin Shao : Comprehensive Genomic Analysis of Advanced HR+/HER2- Breast Cancer Patients Using Liquid Biopsy

    HR+/HER2- is the most common subtype of breast cancer, accounting for approximately 65% to 70% of all breast cancer cases. Improving the survival benefits for patients with advanced HR+/HER2- breast cancer has always been a hot topic in this field and a unanimous goal for scholars and experts. Exploring the genomic characteristics of advanced HR+/HER2-…

    2024.02.23
  • Prof. Jun Ma Highlights ASH Conference, Showcasing Chinese Influence on Global Stage

    Local time on December 9th, the eagerly awaited 65th American Society of Hematology (ASH) Annual Meeting officially kicked off in San Diego, USA. The Oncology Insight reporting team delved into the forefront, witnessing the impressive presence of “The Voice of China” on the international stage. ASH is one of the largest and most comprehensive international…

    2024.02.23
«previous next»
Recent Posts
  • 2026 Pujiang Urological Oncology Academic Conference丨Chunguang Ma: Immunotherapy Opens a New Era in Adjuvant Treatment for Urothelial Carcinoma—From a Shift in Perioperative Concepts to Precision Whole-Course Management
  • Professor Yongmei Yin: Advancing Precision Oncology from Concept to Clinical Practice — Key Insights from the 2026 “Renyi” Clinical Research Conference on Innovative Anticancer Drugs
  • 2026 Northern Breast Cancer Salon · Getting to the Bottom of It丨Professors Wenyan Chen and Ning Xie: Treatment Options for HER2-Positive Metastatic Breast Cancer After Failure of H-Based Therapy
  • 2026 Northern Breast Cancer Salon · Time & Memory丨Professor Guohong Song: Breaking New Ground and Advancing Further — The Evolution of HER2-Positive Breast Cancer Treatment and the New Treatment Landscape in the ADC Era
  • 2026 Northern Breast Cancer Salon · Time & Memory | Professor Yongmei Yin: Seeing the Subtle to Foresee the Far — The Evolution of Precision Diagnosis and Treatment in Breast Cancer from Molecular Subtyping to Gene-Guided Therapy
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top